共 50 条
- [41] De novo entecavir plus adefovir dipivoxil plus lamivudine triple-resistance mutations resulting from sequential therapy with adefovir dipivoxil, and lamivudine [J]. ANNALS OF CLINICAL MICROBIOLOGY AND ANTIMICROBIALS, 2016, 15
- [42] De novo entecavir+adefovir dipivoxil+lamivudine triple-resistance mutations resulting from sequential therapy with adefovir dipivoxil, and lamivudine [J]. Annals of Clinical Microbiology and Antimicrobials, 15
- [45] Study on comparison of efficacy of entecavir and adefovir dipivoxil in treatment of hepatitis B cirrhosis [J]. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2021, 14 (05): : 1892 - 1899
- [47] Performance of adefovir dipivoxil and lamivudine in the treatment of chronic hepatitis B with YMDD viral mutants [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2004, 99 (10): : S89 - S89